{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T21:29:19Z","timestamp":1785446959017,"version":"3.56.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,12]],"date-time":"2021-09-12T00:00:00Z","timestamp":1631404800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedical Journal"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.bj.2021.09.002","type":"journal-article","created":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T03:15:40Z","timestamp":1632107740000},"page":"229-239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Pharmacological therapy for Tourette syndrome: What medicine can do and cannot do"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6021-0542","authenticated-orcid":false,"given":"Yoshiko","family":"Nomura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bj.2021.09.002_bib1","first-page":"277","article-title":"Gilles de la Tourette's syndrome: summary of clinical experience with 250 patients and suggested nomenclature for tic syndromes","volume":"14","author":"Shapiro","year":"1976","journal-title":"Adv Neurol"},{"key":"10.1016\/j.bj.2021.09.002_bib2","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1176\/ajp.133.8.944","article-title":"A follow-up of 78 patients with Gilles de la Tourette's syndrome","volume":"133","author":"Bruun","year":"1976","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.bj.2021.09.002_bib3","series-title":"Gilles de la Tourette syndrome","first-page":"119","article-title":"Signs, symptoms, and clinical course","author":"Shapiro","year":"1978"},{"key":"10.1016\/j.bj.2021.09.002_bib4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0387-7604(79)80018-2","article-title":"Gilles de la Tourette syndrome in Oriental children","volume":"1","author":"Nomura","year":"1979","journal-title":"Brain Dev"},{"key":"10.1016\/j.bj.2021.09.002_bib5","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S0387-7604(03)90005-2","article-title":"Tourette's syndrome in Taiwan: an epidemiological study of tic disorders in an elementary school at Taipei County","volume":"25","author":"Wang","year":"2003","journal-title":"Brain Dev"},{"key":"10.1016\/j.bj.2021.09.002_bib6","series-title":"Tourette's syndrome \u2013 tics, obsessions, compulsion, developmental psychopathology and clinical care","first-page":"194","article-title":"Genetic vulnerability","author":"Pauls","year":"1999"},{"key":"10.1016\/j.bj.2021.09.002_bib7","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/S0387-7604(03)90011-8","article-title":"Neurophysiology of Tourette's syndrome: pathophysiological considerations","volume":"25","author":"Segawa","year":"2003","journal-title":"Brain Dev"},{"key":"10.1016\/j.bj.2021.09.002_bib8","first-page":"1373","article-title":"Tourette syndrome: clinical features and pathophysiology","volume":"69","author":"Nomura","year":"2017","journal-title":"Brain Nerve"},{"key":"10.1016\/j.bj.2021.09.002_bib9","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/brain\/123.3.425","article-title":"Tourette syndrome, associated conditions and the complexities of treatment","volume":"123","author":"Robertson","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.bj.2021.09.002_bib10","series-title":"Movement disorders in children international review of child neurology series","first-page":"1","author":"Fernandez-Alvarez","year":"2001"},{"key":"10.1016\/j.bj.2021.09.002_bib11","series-title":"Tourette's syndrome \u2013 tics, obsessions, compulsion, developmental psychopathology and clinical care","first-page":"23","article-title":"Tics and tic disorder","author":"Leckman","year":"1999"},{"key":"10.1016\/j.bj.2021.09.002_bib12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1542\/peds.102.1.14","article-title":"Course of tic severity in Tourette syndrome: the first two decades","volume":"102","author":"Leckman","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.bj.2021.09.002_bib13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/schbul\/8.2.267","article-title":"The epidemiology of Tourette's syndrome: a pilot study","volume":"8","author":"Jagger","year":"1982","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.bj.2021.09.002_bib14","series-title":"Adv neurol","first-page":"1","article-title":"The natural history of Tourette syndrome","volume":"vol. 58","author":"Bruun","year":"1992"},{"key":"10.1016\/j.bj.2021.09.002_bib15","first-page":"73","article-title":"Tic Disorders \u2013 ageing changes of clinical features and long term prognosis","volume":"16","author":"Nomura","year":"1998","journal-title":"Clin Neurosci"},{"key":"10.1016\/j.bj.2021.09.002_bib16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00002826-197600010-00006","article-title":"The pharmacology of gilles de la Tourette's syndrome (chronic multiple tic)","volume":"1","author":"Sweet","year":"1976","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.bj.2021.09.002_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00005792-199101000-00002","article-title":"Tourette syndrome and other tic disorders. Diagnosis, pathophysiology, and treatment","volume":"70","author":"Singer","year":"1991","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.bj.2021.09.002_bib18","series-title":"Tourette syndrome","first-page":"370","article-title":"Pharmacological and other somatic approaches to treatment","author":"Carpenter","year":"1999"},{"key":"10.1016\/j.bj.2021.09.002_bib19","first-page":"219","article-title":"Clinical diagnosis and management of Tourette syndrome","volume":"10","author":"Wang","year":"2001","journal-title":"Acta Neurol Taiwan"},{"key":"10.1016\/j.bj.2021.09.002_bib20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.tins.2006.01.001","article-title":"Recent advances in Tourette syndrome research","volume":"29","author":"Albin","year":"2006","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.bj.2021.09.002_bib21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11910-001-0016-8","article-title":"The treatment of tics","volume":"1","author":"Singer","year":"2001","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.bj.2021.09.002_bib22","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s11940-010-0095-4","article-title":"Treatment of tics and Tourette syndrome","volume":"12","author":"Singer","year":"2010","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.bj.2021.09.002_bib23","first-page":"896","article-title":"Practice guideline recommendations summary: treatment of tics in people with Tourette syndrome and chronic tic disorders","volume":"92","author":"Pringsheim","year":"2019"},{"key":"10.1016\/j.bj.2021.09.002_bib24","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1080\/14737175.2019.1643236","article-title":"Evidence-based treatment of Tourette's disorder and chronic tic disorders","volume":"19","author":"Essoe","year":"2019","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.bj.2021.09.002_bib25","first-page":"323","article-title":"Social adaptation of Tourette syndrome families in Japan","volume":"58","author":"Nomura","year":"1992","journal-title":"Adv Neurol"},{"key":"10.1016\/j.bj.2021.09.002_bib26","first-page":"578","article-title":"Un cas de maladie des tics de Gilles de la Tourette gueri par le R-1625","volume":"119","author":"Seignot","year":"1961","journal-title":"Ann Med-Psychol"},{"key":"10.1016\/j.bj.2021.09.002_bib27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0140-6736(77)91126-6","article-title":"Comparison of pimozide with haloperidol in Gilles de la Tourette synndrome","volume":"1","author":"Ross","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.bj.2021.09.002_bib28","series-title":"Presented at Vth world congress of psychiatry, Honolulu","article-title":"Gilles de la Tourette syndrome in oriental children","author":"Nomura","year":"1977"},{"key":"10.1016\/j.bj.2021.09.002_bib29","first-page":"391","article-title":"Clonidine in the treatment of Tourette syndrome: a review of data","volume":"35","author":"Leckman","year":"1982","journal-title":"Adv Neurol"},{"key":"10.1016\/j.bj.2021.09.002_bib30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1212\/WNL.35.3.343","article-title":"Short and long-term treatment of Tourette syndrome with clonidine: a clinical perspective","volume":"35","author":"Leckman","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.bj.2021.09.002_bib31","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/archpsyc.1991.01810280040006","article-title":"Clonidine treatment of Gilles de la Tourette's syndrome","volume":"48","author":"Leckman","year":"1991","journal-title":"Arch Gen Psychiatr"},{"key":"10.1016\/j.bj.2021.09.002_bib32","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/ana.410210313","article-title":"Clonidine and Gilles de la Tourette syndrome: double-blind study using objective rating method","volume":"21","author":"Goetz","year":"1987","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bj.2021.09.002_bib33","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(94)90389-1","article-title":"Risperidone for Tourette's syndrome","volume":"344","author":"Stamenkovic","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.bj.2021.09.002_bib34","first-page":"29","article-title":"Risperidone as a treatment for Tourette's syndrome","volume":"57","author":"Bruun","year":"1996","journal-title":"J Clin Psychiatr"},{"key":"10.1016\/j.bj.2021.09.002_bib35","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1469-8749.1974.tb02715.x","article-title":"Gilles de la Tourette's syndrome following methylphenidate administration","volume":"16","author":"Golden","year":"1974","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.bj.2021.09.002_bib36","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3928\/0090-4481-19880601-08","article-title":"The relationship between stimulant medication and tics","volume":"17","author":"Golden","year":"1988","journal-title":"Pediatr Ann"},{"key":"10.1016\/j.bj.2021.09.002_bib37","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1176\/appi.ajp.160.6.1175","article-title":"Habit reversal versus supportive psychotherapy for Tourette's disorder: a randomized controlled trial","volume":"160","author":"Wilhelm","year":"2003","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.bj.2021.09.002_bib38","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/jcap.12002","article-title":"Habit reversal training for children with Tourette syndrome: update and review","volume":"25","author":"Hwang","year":"2012","journal-title":"J Child Adolesc Psychiatr Nurs"},{"issue":"19","key":"10.1016\/j.bj.2021.09.002_bib39","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1001\/jama.2010.607","article-title":"Behavior therapy for children with Tourette disorder: a randomized controlled trial","volume":"303","author":"Piacentini","year":"2010","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.bj.2021.09.002_bib40","first-page":"33","article-title":"Deep brain stimulation in movement disorders. The applications reconsidered","volume":"104","author":"Visser-Vandewalle","year":"2004","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.bj.2021.09.002_bib41","doi-asserted-by":"crossref","first-page":"E590","DOI":"10.1227\/01.NEU.0000207959.53198.D6","article-title":"Deep brain stimulation in Gilles de la Tourette's syndrome","volume":"58","author":"Visser-Vandewalle","year":"2006","journal-title":"Neurosurgery"},{"key":"10.1016\/j.bj.2021.09.002_bib42","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.0000000000007467","article-title":"Comprehensive systematic review summary: treatment of tics in people with Tourette syndrome and chronic tic disorders","volume":"92","author":"Pringsheim","year":"2019","journal-title":"Neurol"},{"key":"10.1016\/j.bj.2021.09.002_bib43","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/ana.410120408","article-title":"Dopaminergic dysfunction in Tourette syndrome","volume":"12","author":"Singer","year":"1982","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bj.2021.09.002_bib44","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0887-8994(01)00262-4","article-title":"Basal ganglia dysfunction in Tourette's syndrome: a new hypothesis","volume":"25","author":"Mink","year":"2001","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.bj.2021.09.002_bib45","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/S0387-7604(03)90007-6","article-title":"Neurology of Tourette's syndrome (TS) TS as a developmental dopamine disorder: a hypothesis","volume":"25","author":"Nomura","year":"2003","journal-title":"Brain Dev"},{"key":"10.1016\/j.bj.2021.09.002_bib46","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/ajmg.b.20065","article-title":"Children at familial risk for Tourette's disorder: child and parent diagnoses","volume":"121B","author":"McMahon","year":"2003","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.bj.2021.09.002_bib47","series-title":"New concept in neurotransmitter regulation","first-page":"53","article-title":"Some characteristics of brain tyrosine hydroxylase","author":"McGeer","year":"1973"},{"key":"10.1016\/j.bj.2021.09.002_bib48","series-title":"Age-related dopamine-dependent disorders, monographs in neural sciences","first-page":"216","article-title":"Catecholaminergic systems and the sexual differentiation of the brain","volume":"vol. 14","author":"Reisert","year":"1995"},{"key":"10.1016\/j.bj.2021.09.002_bib49","first-page":"520","article-title":"Rotational seizures in tuberous sclerosis","volume":"34","author":"Tanaka","year":"1989","journal-title":"Jutendo-Igaku (Tokyo)"},{"key":"10.1016\/j.bj.2021.09.002_bib50","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/hup.2498","article-title":"Aripiprazole for Tourette's syndrome: a systematic review and meta-analysis","volume":"31","author":"Zheng","year":"2016","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.bj.2021.09.002_bib51","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1089\/cap.2016.0026","article-title":"Randomized, double-blind, placebo-controlled trial demonstrates the efficacy and safety of oral aripiprazole for the treatment of tourette's disorder in children and adolescents","volume":"27","author":"Sallee","year":"2017","journal-title":"J Child Adolesc Psychopharmacol"}],"container-title":["Biomedical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417021001141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417021001141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:11:21Z","timestamp":1762420281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2319417021001141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S2319417021001141"],"URL":"https:\/\/doi.org\/10.1016\/j.bj.2021.09.002","relation":{},"ISSN":["2319-4170"],"issn-type":[{"value":"2319-4170","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological therapy for Tourette syndrome: What medicine can do and cannot do","name":"articletitle","label":"Article Title"},{"value":"Biomedical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bj.2021.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Chang Gung University. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}